Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Appointed director

Lucira Health, Inc. (LHDX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
08/15/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
06/29/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/29/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/12/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Disclosure Statement for Chapter 11 Plan of Liquidation for Lucira Health, Inc",
"Chapter 11 Plan of Liquidation for Lucira Health, Inc"
04/24/2023 8-K Quarterly results
04/18/2023 8-K Quarterly results
04/13/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
04/05/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Monthly Operating Report, for the period covering February 1, 2023 through February 28, 2023, filed with the United States Bankruptcy Court for the District of Delaware",
"Monthly Operating Report, for the period covering February 1, 2023 through February 28, 2023, filed with the United States Bankruptcy Court for the District of Delaware"
03/13/2023 4 Engelson Erik T. (President and Chief Executive) has filed a Form 4 on Lucira Health, Inc.
Txns: Sold 574,666 shares @ $1.03, valued at $591.9k
Sold 60,000 shares @ $1.09, valued at $65.4k
Exercised 574,666 options to buy @ $0.82, valued at $471.2k
03/13/2023 4 Narido Richard Clavano (CFO) has filed a Form 4 on Lucira Health, Inc.
Txns: Sold 10,674 shares @ $1.14, valued at $12.2k
Sold 9,675 shares @ $1.07, valued at $10.4k
Sold 4,742 shares @ $1, valued at $4.7k
Sold 1,910 shares @ $0.57, valued at $1.1k
Sold 2,382 shares @ $0.45, valued at $1.1k
03/13/2023 4 Collins Kevin Walter (Chief Revenue Officer) has filed a Form 4 on Lucira Health, Inc.
Txns: Sold 30,102 shares @ $1.15, valued at $34.6k
Sold 81,717 shares @ $0.48, valued at $39.2k
03/13/2023 4 Allen Anthony Joseph (Chief Operations Officer) has filed a Form 4 on Lucira Health, Inc.
Txns: Sold 8,405 shares @ $1, valued at $8.4k
02/27/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"LUCIRA HEALTH ANNOUNCES FDA AUTHORIZATION OF FIRST & ONLY AT-HOME COMBINATION COVID-19 & FLU TEST AND COMMENTS ON CHAPTER 11 BANKRUPTCY FILING"
02/22/2023 8-K Bankruptcy or Receivership, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer...
Docs: "Lucira Health to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process"
01/13/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/28/2022 8-K Quarterly results
12/22/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 8-K Quarterly results
12/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/15/2022 8-K Quarterly results
12/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/25/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
11/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/14/2022 8-K Quarterly results
11/01/2022 8-K Quarterly results
10/26/2022 8-K Quarterly results
09/22/2022 4 Allen Anthony Joseph (Chief Operations Officer) has filed a Form 4 on Lucira Health, Inc.
Txns: Sold 17,052 shares @ $1.39, valued at $23.7k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy